4552.T

JCR Pharmaceuticals Co., Ltd.
TokyoJPYEQUITY Healthcare DELAYED
Last price
530.00
▼ 16.00 (2.93%)
MARKET ·

Price

Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
536.00
Prev close
546.00
Day high
543.00
Day low
529.00
Volume
454.40K
Market cap
$64.55B
P/E (TTM)
29.59
52W range
444.00 – 824.00

Day trading desk

Current session · delayed
Gap from prior close
-1.83%
Prior close 546.00
VWAP
532.42
-0.45% from price
Relative volume
0.50×
Quiet session
Session range
1.51%
529.00 – 537.00
Position in range
13%
Near session low
ATR (14D)
18.36
3.46% of price
Prior day high
546.00
PDH
Prior day low
534.00
PDL
Bid / ask spread
Quote not published
Session volume
332.10K
Avg 666.52K

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+0.57% +1.9%
1M
+1.34% -2.4%
3M
+4.55% +1.4%
6M
-20.21% -31.3%
YTD
-25.70% -38.0%
1Y
-17.21% -37.2%
3Y
-57.46% -131.6%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on 4552.T open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
45.12M
Total on file

Fundamentals

TTM · reported
Market cap$64.55B
Enterprise value$109.25B
Revenue (TTM)$41.45B
Gross profit$31.42B
EBITDA$1.32B
Net income$817.00M
EPS (TTM)$17.88
Free cash flow
Total cash$9.66B
Total debt$53.94B
Book value / share$354.14
Shares outstanding122.02M
Float73.68M
Short % of float
Dividend yield3.78%
Beta (5Y)0.17

Valuation & profitability ratios

Account required
Trailing P/E29.59
Forward P/E14.45
PEG ratio1.17
Price / sales
Price / book1.49
EV / revenue2.64
EV / EBITDA82.47
Gross margin75.81%
Operating margin-21.68%
Profit margin1.97%
Return on equity1.90%
Return on assets-0.60%
Debt / equity123.64
Current ratio1.09
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 5 years · 3 quarters
Blank means not reported, not zero
Line item2026202520242023YoY
Total revenue $40.32B$33.07B$42.87B$34.34B +21.9%
Operating revenue $40.32B$33.07B$42.87B$34.34B +21.9%
Cost of revenue $10.13B$10.90B$11.62B$8.89B -7.0%
Gross profit $30.18B$22.17B$31.25B$25.46B +36.2%
Total operating expense $29.63B$28.39B$23.72B$20.48B +4.4%
Operating income $556.00M-$6.22B$7.53B$4.98B +108.9%
Net interest income -$317.00M-$42.00M$25.00M-$11.00M -654.8%
Pre-tax income $3.22B-$5.98B$7.24B$5.41B +153.9%
Tax provision $1.02B-$1.59B$1.71B$1.63B +164.1%
Net income $2.18B-$4.46B$5.51B$3.77B +148.8%
Net income to common $2.18B-$4.46B$5.51B$3.77B +148.8%
Basic EPS 17.87-36.0244.1330.35 +149.6%
Diluted EPS 17.87-36.0243.9230.22 +149.6%
EBIT $3.62B-$5.83B$7.33B$5.46B +162.1%
EBITDA $6.18B-$2.45B$10.53B$7.45B +351.8%
Basic shares 121.88M123.82M124.79M124.31M -1.6%
Diluted shares 121.88M123.82M125.39M124.82M -1.6%

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Reported vs expected · EPS
QuarterEst.ActualSurprise
Jun 2026 -11.27-15.64 -38.8%
Dec 2025 -1.070.27 +125.2%
Sep 2025 18.6718.51 -0.9%
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter 0.17 1 $12.03B -5.9%
Next quarter -13.83 1 $13.59B +51.2%
Current year 2.83 5 $43.81B +8.6%
Next year 5.95 5 $41.44B -5.4%

Analyst targets & ownership

Account required
Mean target$618.33
High target$900.00
Low target$500.00
Implied upside16.67%
Analyst count6
ConsensusHOLD
Strong buy / Buy0 / 1
Hold5
Sell / Strong sell0 / 0
Held by insiders36.97%
Held by institutions13.64%
Institutions holding35
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
519.60
+2.00% from price
SMA 20
509.50
+3.83% from price
SMA 50
487.30
+8.56% from price
SMA 100
511.93
+3.53% from price
SMA 200
589.45
-10.26% from price
EMA 12
518.67
+2.18% from price
EMA 26
508.21
+4.29% from price
EMA 50
504.08
+5.14% from price
RSI (14)
57.2
Neutral
MACD (12,26,9)
10.47
Hist 2.71
ATR (14)
18.36
3.47% of price
Realised vol 30D
44.3%
Annualised
Bollinger upper
549.96
20, 2σ
Bollinger lower
469.04
20, 2σ
50 / 200 cross
Death
487.30 vs 589.45
Trend bias
Below 200
-10.26%

Options chain

Account required
ExpirySpot 530.00
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
-0.18
Less volatile than market
Correlation to SPY
-0.06
Largely independent
Realised vol 30D
44.3%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-43.2%
Peak to trough
Max drawdown 5Y
-87.5%
Peak to trough
ATR 14
18.36
3.47% of price
Beta (reported)
0.17
5Y monthly, from filing

Dividends & splits

Declared · from the issuer
Forward rate$20.00 / yr
Forward yield3.78%
5-year avg yield2.22%
Payout ratio111.98%
Ex-dividend dateSep 29, 2026
Next pay date
Last split4:1
Split dateSep 30, 2020

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.